Advertisement
Australia markets close in 1 hour 7 minutes
  • ALL ORDS

    7,859.00
    -52.50 (-0.66%)
     
  • ASX 200

    7,606.10
    -52.90 (-0.69%)
     
  • AUD/USD

    0.6570
    +0.0019 (+0.28%)
     
  • OIL

    78.27
    +0.09 (+0.12%)
     
  • GOLD

    2,041.70
    +1.90 (+0.09%)
     
  • Bitcoin AUD

    79,150.15
    +674.55 (+0.86%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • AUD/EUR

    0.6071
    +0.0016 (+0.26%)
     
  • AUD/NZD

    1.0613
    -0.0008 (-0.07%)
     
  • NZX 50

    11,579.75
    +8.53 (+0.07%)
     
  • NASDAQ

    17,546.10
    -139.88 (-0.79%)
     
  • FTSE

    7,719.21
    -9.29 (-0.12%)
     
  • Dow Jones

    38,563.80
    -64.19 (-0.17%)
     
  • DAX

    17,068.43
    -23.83 (-0.14%)
     
  • Hang Seng

    16,726.22
    +478.71 (+2.95%)
     
  • NIKKEI 225

    38,137.19
    -226.42 (-0.59%)
     

Compared to Estimates, Surgery Partners (SGRY) Q3 Earnings: A Look at Key Metrics

Surgery Partners (SGRY) reported $674.1 million in revenue for the quarter ended September 2023, representing a year-over-year increase of 8.6%. EPS of $0.19 for the same period compares to -$0.02 a year ago.

The reported revenue compares to the Zacks Consensus Estimate of $670.74 million, representing a surprise of +0.50%. The company delivered an EPS surprise of +35.71%, with the consensus EPS estimate being $0.14.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Surgery Partners performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Cases: 146,514 versus the two-analyst average estimate of 153,180.

  • Number of consolidated surgical facilities as of the end of period: 117 versus 120 estimated by two analysts on average.

  • Revenue per case: $4,601 compared to the $4,370.99 average estimate based on two analysts.

  • Number of surgical facilities as of the end of period: 154 versus the two-analyst average estimate of 153.

View all Key Company Metrics for Surgery Partners here>>>

Shares of Surgery Partners have returned -10.1% over the past month versus the Zacks S&P 500 composite's +1.5% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Surgery Partners, Inc. (SGRY) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research